Roots Analysis has announced the addition of “Bacteriophage Therapeutics Market, 2022-2035” report to its list of offerings.
Key Market Insights
§ Over 100 bacteriophage therapeutics have either been marketed / are being developed by various well-established and small firms; majority of these therapeutics are being evaluated for the treatment of infectious...
The Bacteriophage Therapy Market is US$ 45.1 million, and is expected to reach US$ 74.2 million by 2031 at a CAGR of 6.4%.
FutureWise Research published a report that analyzes Bacteriophage Therapy Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends...
Bacteriophage therapy, also known as phage therapy, is a medical application of bacteriophages to treat pathogenic bacterial infections. Bacteriophages are viruses that infect and replicate within bacteria and cause lysis of bacterial cells. Phage therapy involves isolation of specific bacteriophages that infect the targeted bacterial pathogen, amplification, and application through various...
Bacteriophage therapy, also known as phage therapy, is the therapeutic use of bacteriophages to treat pathogenic bacterial infections. Phage can be administered for both internal and external use to treat infections like bacterial diarrhea, ulcers, food poisoning, respiratory infections, as well as ear, eye, and skin infections. Phage therapy is considered promising because phage are non-toxic...